Cisplatin‐induced HSF1‐HSP90 axis enhances the expression of functional PD‐L1 in oral squamous cell carcinoma

Immune checkpoint inhibitor‐based cancer immunotherapy has provided an additional therapeutic option for oral squamous cell carcinoma (OSCC) with recurrence or distant metastases. However, further improvement of OSCC treatment is required to develop the optimal combination or order for chemoradiothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaya, Takashi, Kubo, Terufumi, Murata, Kenji, Mizue, Yuka, Sasaki, Kenta, Yanagawa, Junko, Imagawa, Makoto, Kato, Hirotaka, Tsukahara, Tomohide, Kanaseki, Takayuki, Tamura, Yasuaki, Miyazaki, Akihiro, Hirohashi, Yoshihiko, Torigoe, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972142/
https://www.ncbi.nlm.nih.gov/pubmed/36200687
http://dx.doi.org/10.1002/cam4.5310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972142/
https://www.ncbi.nlm.nih.gov/pubmed/36200687
http://dx.doi.org/10.1002/cam4.5310

Ejemplares similares